Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery
Sponsor : AbCellera
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The collaboration aims for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets, leveraging confo's proprietary ConfoBody® technology to stabilize the selected GPCRs in their disease-relevant conformations.
Product Name : Undisclosed
Product Type : Other Large Molecule
Upfront Cash : Undisclosed
June 15, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery
Sponsor : AbCellera
Deal Size : Undisclosed
Deal Type : Collaboration